Overview
Mohammed Khalil is an Ophthalmologist in New York, New York. Dr. Khalil is rated as an Experienced provider by MediFind in the treatment of Retinoblastoma. His top area of expertise is Retinoblastoma.
His clinical research consists of co-authoring 3 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Retinoblastoma.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Mskcc Surgery Group
David Abramson is an Ophthalmologist in New York, New York. Dr. Abramson is rated as an Elite provider by MediFind in the treatment of Retinoblastoma. His top areas of expertise are Retinoblastoma, Hereditary Retinoblastoma, Melanoma of the Eye, Vitrectomy, and Leg or Foot Amputation.
Trustees Of Columbia University In The City Of New York
Brian Marr is an Ophthalmologist in New York, New York. Dr. Marr is rated as a Distinguished provider by MediFind in the treatment of Retinoblastoma. His top areas of expertise are Retinoblastoma, Melanoma of the Eye, Metastatic Uveal Melanoma, Uveal Melanoma, and Vitrectomy.
Trustees Of Columbia University In The City Of New York
Scott Brodie is an Ophthalmologist in New York, New York. Dr. Brodie is rated as a Distinguished provider by MediFind in the treatment of Retinoblastoma. His top areas of expertise are Retinoblastoma, Retinitis Pigmentosa, Retinopathy Pigmentary Mental Retardation, Cone-Rod Dystrophy, and Vitrectomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers